<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Fri, 24 May 2013 19:30:43 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>Pfizer Inc. to Stay in Madison, 475 Jobs Saved  </title><link>http://www.nj.com/morris/index.ssf/2013/05/pfizer_to_stay_in_madison.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Two months after Pfizer announced the sale of its property at 5 Giralda Farms, the company says it's only moving across the corporate campus. Pfizer Consumer Health has entered into a lease agreement for its...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Ranbaxy Laboratories Rumored to Cut One-Third of Global Sales Force, Mainly in U.S.: Source  </title><link>http://www.pharmatimes.com/Article/13-05-23/Job_cuts_rumour_at_Ranbaxy_as_firm_rectifies_past_mistakes.aspx</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Even as trouble thickens for drug maker Ranbaxy Laboratories, the company is now considering downsizing its global sales force by around a third. A majority of the job cuts would be in the US, it is learnt...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>GlaxoSmithKline to Shut Packaging Plant in Boronia, Laying Off 120 Workers  </title><link>http://www.theaustralian.com.au/news/breaking-news/glaxosmithkline-to-axe-120-jobs/story-fn3dxiwe-1226648106500</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;SYDNEYGlaxoSmithKline GSK.LN 1.78% PLC said it would close an Australian tablet-packaging facility and lay off 120 workers, joining a string of manufacturers that have shut factories, slashed jobs and relocated...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Actavis "Moves" to Ireland for a Lower Tax Rate  </title><link>http://www.pharmalive.com/with-warner-chilcott-deal-actavis-moves-to-ireland-for-a-lower-tax-rate</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;If there is a take-away message from the $8.5 billion deal in which Actavis is going to buy Warner-Chilcott, it would be that taxes matter. How so? As part of the acquisition, Actavis is going to declare its...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Bickering Continues Over Sanofi (France) R&amp;D Site  </title><link>http://www.reuters.com/article/2013/05/17/us-sanofi-toulouse-idUSBRE94G0CY20130517</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Sanofi (SAN) and the French government presented conflicting views on plans for the future of the drugmakers research site in Toulouse, further complicating the companys reorganization attempts. Industry Minister...</description><pubDate>Fri, 17 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Quintiles, Inc. Cutting 400 Jobs Worldwide This Year  </title><link>http://www.newsobserver.com/2013/05/14/2892710/quintiles-cutting-400-jobs-worldwide.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; On the heels of last weeks successful initial public offering that raised hundreds of million of dollars from investors, pharmaceutical services giant Quintiles disclosed Tuesday in a securities filing that...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Astellas Pharma Inc. Shuts Down OSI Pharmaceuticals, Inc., Perseid in Restructuring of R&amp;D Ops, Cuts 200 Jobs  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296532&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;b&gt;Reshaping Research Framework to Enhance the Ability to Generate Innovative Drugs&lt;/b&gt;&lt;br&gt;&lt;br&gt;Tokyo, Japan, May 14, 2013 - Astellas Pharma Inc. (Tokyo:4503, President and CEO: Yoshihiko Hatanaka, hereinafter...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. to Close Little Island Plant - 136 Jobs Lost  </title><link>http://www.rte.ie/news/business/2013/0515/450359-pfizer-jobs/</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?CustomerId394762&amp;typeseo-article&amp;source"job-search""&gt;Hey, Pfizer's hiring! (Isnt it tempting?)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;The jobs of more than 130 people are under threat at a manufacturing plant operated by pharmaceutical company Pfizer in Co Cork. Pfizer has said it plans to withdraw from the plant at Little Island over the next 18 months. However...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Bad Night: Purdue Pharma L.P. Axes 90 Reps of Transcept Pharmaceuticals, Inc. Sleep Drug  </title><link>http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/05/transcept-intermezzo-tspt-purdue-sleep.html?ana=otj</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Purdue Pharmaceuticals LP will shelve 90 contract sales people it used to exclusively hawk the Transcept Pharmaceuticals Inc.-developed middle-of-the-night sleep drug Intermezzo. Intermezzo will continue to...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. Lays Off 25 After Levoxyl Recall  </title><link>http://www.tricities.com/news/local/article_d109a908-bc37-11e2-89fa-0019bb30f31a.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Pfizer recently released about a fifth of its remaining local workforce, following a second recall of the drug Levoxyl. About 25 full-time workers at the companys Fifth Street facility were released in early...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Millennium Pharmaceuticals, Inc.&lt;/b&gt; CEO Out as Takeda Pharmaceutical Co. Ltd. Reorganizes, Cuts Costs  </title><link>http://www.xconomy.com/boston/2013/05/09/dunsire-out-at-millenniumtakeda-replaced-by-anna-protopapas/</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Deborah Dunsire, the CEO who led Millennium Pharmaceuticals to prominence in cancer treatment, is leaving the company in an abrupt departure five years after it was acquired by Japan-based Takeda Pharmaceuticals...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Bayer HealthCare AG Lays Off 50 at  </title><link>http://www.bizjournals.com/pittsburgh/news/2013/05/09/bayer-healthcare-lays-off-50-at-medrad.html?ana=otj</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;A realignment of Bayer HealthCares Radiology and Interventional business is resulting in the layoff of roughly 50 people, the company said. The Radiology and Interventional business is a former Medrad business...</description><pubDate>Fri, 10 May 2013 12:00:00 AM GMT</pubDate></item><item><title>PRA International, Inc.: 100 New Jobs Created as Company Expands  </title><link>http://www.walesonline.co.uk/news/business/business-news/pra-announces-100-job-expansion-3474702</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;An expansion of a clinical research company in Swansea will create 100 jobs, according to the firm. US company PRA is doubling the number of its employees in the city following 1.29m of Welsh government support...</description><pubDate>Thu, 09 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Catalent Pharma Solutions Project May Create 30 Jobs in Winchester  </title><link>http://www.centralkynews.com/winchestersun/news/ws-catalent-pharma-solutions-project-may-create-30-jobs-in-winchester-20130508,0,4849969.story</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;The Winchester-Clark County Planning Commission unanimously approved a final development plan for a proposed expansion to Catalent Pharma Solutions Tuesday evening. Located at 1100 Enterprise Drive in the Winchester...</description><pubDate>Thu, 09 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Cardinal Health, Inc. Laying Off 70 in Ohio, 170 Total  </title><link>http://www.dispatch.com/content/stories/business/2013/05/07/cardinal-health-layoff.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Cardinal Health will lay off about 170 employees, including 70 from its Dublin headquarters. The jobs are primarily in the companys pharmaceutical segment and in corporate support, said Cardinal spokeswoman...</description><pubDate>Wed, 08 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Eli Lilly and Company Job Cuts Almost Double Original Numbers in Detailed Report  </title><link>http://www.insideindianabusiness.com/newsitem.asp?ID=59288#middle</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?CustomerId395010&amp;typeseo-article&amp;sourcejob-search"&gt;Hey, Eli Lilly's hiring! (Isnt it tempting?)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;Eli Lilly and Co.s massive restructuring of its sales force will affect more employees than the Indianapolis-based drugmaker disclosed in early April. Lilly will eliminate 1,624 positions from its U.S. sales force in July, according...</description><pubDate>Wed, 08 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Medical Products Laboratories, Inc.&lt;/b&gt; Expanding Facility in Philadelphia to Create 14 Jobs  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295817&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;HARRISBURG, Pa.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 8, 2013&lt;/span&gt; /PRNewswire-USNewswire/ -- Governor &lt;span class"xn-person"&gt;Tom Corbett&lt;/span&gt; today announced that Medical Products Laboratories, Inc. will...</description><pubDate>Wed, 08 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Novartis AG to Cut 300 Jobs in OTC Plant Restructuring After Form 483  </title><link>http://www.in-pharmatechnologist.com/Processing/Novartis-to-Cut-300-Jobs-in-OTC-Plant-Restructuring-After-Form-483</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?CustomerId396471&amp;typeseo-article&amp;sourcejob-search"&gt;Hey, Novartis' hiring! (Isnt it tempting?)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;Novartis says both its Swiss plant and third-parties will support its consumer health lines as it restructures its Nebraska facility following a FDA Form 483.&lt;br&gt;&lt;br&gt;&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Redx Pharma Creates 120 New Jobs at Site Being Vacated by AstraZeneca PLC  </title><link>http://www.manchestereveningnews.co.uk/business/business-news/redx-pharma-launch-rd-centre-3415400</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Liverpool-based Redx Pharma's new venture will create 120 jobs at the site, with a further 28 specialist roles expected to be created within the wider supply chain. The site is owned and operated by AZ, which...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Novo Nordisk A/S Invests $69 Million in Plant, Creating 50 New Production/Engineering Jobs  </title><link>http://www.in-pharmatechnologist.com/Processing/Novo-Nordisk-69m-Plant-Conversion-For-New-Diabetes-Drug</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Novo Nordisk says the $69 investment in its Danish plant will convert capacity ready for its new GLP-1 analogue and is a further commitment to Danish manufacturing.&lt;br&gt;&lt;br&gt;Help employers find you! Check...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Sorenson Forensics Boosts Workforce by 33 Pct in Newly Expanded Lab Space  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295526&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;SALT LAKE CITY--(BUSINESS WIRE)-- Sorenson Forensics today announced that in order to accommodate increased forensic casework needs, the company has boosted its workforce by 33 percent, and has added 20 percent...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Royalty Pharma Warns of Job Cuts if Elan Corporation PLC Bid Accepted  </title><link>http://www.independent.ie/business/irish/royalty-warns-of-job-cuts-if-elan-bid-accepted-29242916.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;New York investment firm Royalty Pharma has warned there could be job cuts in the Irish drug firm Elan if Royalty is successful in its 4.3bn takeover bid for the company. Royalty Pharma said last week...</description><pubDate>Mon, 06 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Teva Pharmaceutical Industries Limited to Shut Down Pennsylvania Facility, Cutting Hundreds of Jobs  </title><link>http://www.phillyburbs.com/news/local/money/teva-to-close-bucks-county-site-by/article_dc6afd71-bf11-538d-9746-4c9c2f52bbbc.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;With net income down 26.7 percent for the first quarter of this year, Teva Pharmaceutical Industries, Ltd., announced Thursday morning that it will close its manufacturing and research facility in Sellersville...</description><pubDate>Fri, 03 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Lonza Inc. Closes Ireland Site as U.S. Manufacturing Issues Causes Shortage of Ipsen's Increlex  </title><link>http://www.in-pharmatechnologist.com/Ingredients/Lonza-Closes-Ireland-Site-as-US-Manufacturing-Issues-Cause-Increlex-Shortage</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Manufacturing disruptions at Lonza's Hopkinton, Massachusetts site are causing shortages of Ipsen Biopharmaceuticals growth failure treatment for children in both the US and EU, just as the company announces...</description><pubDate>Wed, 01 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Boehringer Ingelheim Corporation to Restructure in Southern Europe, Jobs at Risk  </title><link>http://www.pmlive.com/pharma_news/boehringer_to_restructure_in_southern_europe_473493</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Boehringer is to close a chemical plant in France as part of plans to adapt its business structure in Southern Europe. Making the announcement at its annual conference in Ingelheim, the German pharma company...</description><pubDate>Fri, 26 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Novartis AG Reduces 40 Pct of Its Total Nebraska Workforce  </title><link>http://www.biospace.com/news_story.aspx?StoryID=294208&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;April 24, 2013&lt;/p&gt;&lt;p&gt;    Group net sales of USD 14.0 billion grew 2% (4% cc[1])&lt;/p&gt;&lt;p&gt;        Core operating income of USD 3.7 billion (3%, 6% cc) grew ahead of sales, improving core operating income...</description><pubDate>Thu, 25 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>454 Life Sciences in Branford Laying Off 60 Workers  </title><link>http://nhregister.com/articles/2013/04/23/business/doc5176eff94ba52781103041.txt</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;A reorganization of a division of Swiss pharmaceutical giant Roche has hit home in Branford with the layoffs of 60 people at the companys 454 Life Sciences subsidiary. The layoffs were implemented Tuesday...</description><pubDate>Wed, 24 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>AstraZeneca PLC Hires Sioux Falls Company Which Plans to Add 50 Jobs  </title><link>http://www.argusleader.com/article/20130417/BJNEWS04/304170016/New-client-prompts-MedVantx-add-50-jobs</link><description>Biopharmaceutical giant AstraZeneca has hired a Sioux Falls company that plans to add 50 jobs to its growing workforce. MedVantx Pharmacy Services operates in relative obscurity in northeastern Sioux Falls. It opened in 2002 at 2503 E. 54th St. N. as a home-delivery pharmacy with four employees under the name AmeriPharm. At the time, the company mailed prescription drugs to patients on group health...</description><pubDate>Wed, 17 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>CoreRx Creating About 25 New Jobs With Construction of New Facility  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293301&amp;full=1</link><description>Clearwater, Florida -- CoreRx, Inc. today announced plans for an approximately $2 million expansion of its manufacturing capabilities in Clearwater, Florida. The expansion will introduce a new facility for hormone development, clinical trial manufacturing and commercial manufacturing capabilities, while adding approximately 25 additional employees to the Clearwater workforce over time.&lt;/p&gt;&lt;p&gt;...</description><pubDate>Tue, 16 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Fresh on the Market AbbVie Axing Hundreds of Jobs to Deal With Patent Losses  </title><link>http://www.bloomberg.com/news/2013-04-16/abbvie-said-to-fire-heart-sales-force-as-generics-compete.html</link><description>AbbVie Inc. (ABBV), the drugmaker split off from Abbott Laboratories (ABT) this year, will fire its sales force for heart drugs as the medicines lose patent protection and face generic competition, according to a person familiar with the matter. The firings total in the mid-hundreds and are a mix of AbbVie employees and contract workers, said the person, who asked not to be identified because they...</description><pubDate>Tue, 16 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Biota Pharmaceuticals&lt;/b&gt; to Shake Things Up and Relocate HQ to Atlanta, Cutting 30 Pct of Staff  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293363&amp;full=1</link><description>ATLANTA, April 15, 2013 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) today announced that its Board of Directors has adopted a revised corporate strategy following the recent completion of management's strategic and operational review of the organization and its various development programs. The implementation of this strategy will shift the Company's primary focus from early-stage...</description><pubDate>Tue, 16 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. Reduces Field Staff Base in India  </title><link>http://www.business-standard.com/article/companies/pfizer-reduces-field-staff-base-in-india-113041600012_1.html</link><description>Employees at global pharma giant Pfizer allege it is cutting its work force in India by insisting they take a voluntary retirement scheme (VRS). The said scheme appears to cover its field force, as well as managerial staff. The company has offered the VRS to at least 270-300 workers so far, sources said. According to them, this is notable as it comes within days of another pharma major, Novartis, losing...</description><pubDate>Tue, 16 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. Shifts Workers Around Boston Area  </title><link>http://bostonherald.com/business/business_markets/2013/04/pfizer_moving_more_workers_to_kendall_square</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?Radius50&amp;CustomerId394762"&gt;Hey, Pfizer's hiring! (Isnt it tempting?)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;A majority of Pfizers 530 research and development employees based in the Alewife section of Cambridge are being relocated to Kendall Square to create a single, integrated community in the area that can easily access and collaborate with world-class biomedical...</description><pubDate>Mon, 15 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Eli Lilly and Company Plans to Lay Off 30 Pct of Its Sales Reps  </title><link>http://www.foxbusiness.com/industries/2013/04/11/report-lilly-to-lay-off-30-us-workforce/</link><description>Pharmaceutical giant Eli Lilly (LLY) plans reduce its U.S. sales group by nearly 1,000 representatives as part of a major restructuring, according to a report Thursday by Dow Jones Newswires. illy plans to add 300 diabetes sales jobs in addition to layoffs, bringing the net loss of sales representatives to less than 1,000 jobs.</description><pubDate>Mon, 15 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Teva Pharmaceutical Industries Limited to Reduce Manufacturing Footprint, Chief Says  </title><link>http://www.bloomberg.com/news/2013-04-11/teva-to-reduce-manufacturing-footprint-chief-levin-says.html</link><description>Teva Pharmaceutical Industries Ltd. (TEVA) is reducing manufacturing operations as part of a cost-cutting effort, though most of the savings under the plan will come from lowering procurement expenses, Chief Executive Officer Jeremy Levin said. Teva, the worlds biggest generic-drug maker, has set a goal of lowering expenses by as much as $2 billion over five years to increase long-term profitability...</description><pubDate>Fri, 12 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Novartis AG Moving 120 Alcon Laboratories, Inc. Jobs to Massachusetts  </title><link>http://www.star-telegram.com/2013/04/09/4762673/novartis-moving-120-alcon-jobs.html</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?Keywordnovartis&amp;Radius50"&gt;Hey, Novartis is hiring! (Isnt it tempting?)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;Swiss pharmaceutical giant Novartis said Tuesday that it is consolidating its U.S.-based eye disease research projects in Cambridge, Mass., and closing the Novartis Institutes for BioMedical Research group on its Alcon Labs campus in Fort Worth. About...</description><pubDate>Thu, 11 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Bristol-Myers Squibb Company to Spend $250 Million to Expand Biologics Facility, Increase Workforce by 350  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293054&amp;full=1</link><description>DEVENS, Mass.--(BUSINESS WIRE)-- Bristol-Myers Squibb (BMY) today announced plans for an approximately $250 million expansion of its large-scale biologics manufacturing facility in Devens, Massachusetts. The expansion will introduce biologics development and clinical trial manufacturing capabilities to the site, while adding approximately 350 employees to the Devens workforce over time.&lt;/p&gt;&lt;p&gt;...</description><pubDate>Thu, 11 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Delcath Systems, Inc. Moving Headquarters to Queensbury, But Plans Job Cuts  </title><link>http://www.businessweek.com/ap/2013-04-09/delcath-shares-fall-further-on-job-cuts</link><description>Delcath Inc. is moving its headquarters to Queensbury, NY. The pharmaceutical and medical device manufacturer has been based in New York City, with the bulk of its operations in two locations in Warren County. Eamonn Hobbs, CEO of Delcath (Nasdaq: DCTH), said the change of address is part an efficiency plan designed to trim expenses as it awaits FDA approval to sell it liver chemotherapy system in...</description><pubDate>Wed, 10 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Unigene Laboratories, Inc. to Slash 40 Pct of Its Workforce  </title><link>http://www.biospace.com/news_story.aspx?StoryID=292756&amp;full=1</link><description>BOONTON, N.J.&lt;/span&gt;, &lt;span class"xn-chron"&gt;April 8, 2013&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;Unigene Laboratories, Inc.&lt;/b&gt; (PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that the Company has entered into a second amendment to a financing agreement with affiliates of Victory Park Capital Advisors, LLC (VPC), whereby VPC has agreed...</description><pubDate>Tue, 09 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Novartis AG Creates 100 Jobs in Ireland  </title><link>http://www.rte.ie/news/business/2013/0408/380354-novartis-jobs-dublin/</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?Keywordnovartis&amp;Radius50"&gt;Hey, Novartis is hiring! (Isnt it tempting?)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;Pharmaceutical company Novartis is to create 100 jobs in Dublin with the establishment of a new business services centre. The development will see consolidation of a range of the company's services including digital marketing, sales-force training and...</description><pubDate>Tue, 09 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Regeneron Pharmaceuticals, Inc. to Expand, Create 400 Jobs in New York  </title><link>http://www.biospace.com/news_story.aspx?StoryID=292390&amp;full=1</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?KeywordRegeneronPharmaceuticals%2cInc.&amp;Radius50&amp;PageIndex1&amp;CustomerId395032"&gt;Hey, Regeneron's hiring! (Isnt it tempting?)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;TARRYTOWN, N.Y.&lt;/span&gt;, &lt;span class"xn-chron"&gt;April 4, 2013&lt;/span&gt; /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Company will expand the Regeneron corporate...</description><pubDate>Fri, 05 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Bristol-Myers Squibb Company Closing Amylin Pharmaceuticals, Inc.'s San Diego Operations, Cutting Hundreds of Employees  </title><link>http://www.utsandiego.com/news/2013/apr/03/amylin-closing-bristol-myers-san-diego/?</link><description>Bristol-Myers Squibb, the drug giant that bought Amylin Pharmaceuticals last summer, plans to shutter its San Diego operations by the end of 2014. The decision closes the books on one of San Diegos most famous biotech companies, a pioneer in new diabetes therapies. It also means hundreds of employees will be dislocated and hundreds of thousands of square feet of office and lab space will be put on...</description><pubDate>Fri, 05 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;BIO Career Fair&lt;/b&gt;: Impress the Best  </title><link>http://www.biotech-now.org/events/2013/03/bio-career-fair-impress-the-best#</link><description>Dont miss an opportunity to spend a day with hiring managers from the nations top biotech firms on April 22 at the  &lt;a href"http://www.biocareerfair.org" target"_blank"&gt;BIO Career Fair&lt;/a&gt; in Chicago. We asked Chanille Hewett, Product Manager for  &lt;a href"http://www.biospace.com" _blank"&gt;Biospace&lt;/a&gt;, host of the BIO Career Fair, to share some ideas on how job seekers can benefit most from attending...</description><pubDate>Thu, 04 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Aastrom Biosciences, Inc. Ends Drug Trial, to Cut Half Its Workforce  </title><link>http://www.thepharmaletter.com/file/121029/aastrom-biosciences-to-re-focus-on-dcm-program-and-cut-workforce.html</link><description>Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia (CLI), a form of peripheral arterial disease, and cut about half of its workforce, driving its shares to an all-time low. The stock was down 34 percent at 75 cents in morning trade on the Nasdaq. The company now plans to focus on developing the drug, ixmyelocel-T, as a treatment for a heart condition...</description><pubDate>Fri, 29 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Solgar Inc.&lt;/b&gt; and Catalent Pharma Solutions' Subsidiary Cut 196 NJ Jobs  </title><link>http://www.northjersey.com/news/199980921_Plant_closures_cut_196_Lyndhurst__Allendale_jobs_announce_layoffs_of_up_to_196.html</link><description>A pharmaceutical manufacturer and a vitamin maker have announced they will each close a North Jersey operation, resulting in up to 196 layoffs in Allendale and Lyndhurst in the latest blow to the manufacturing sector in this part of the state. Solgar Inc., a subsidiary of Ronkonkoma, N.Y.-based manufacturer NBTY, which sells and distributes vitamins and food supplements, announced 107 layoffs in Lyndhurst...</description><pubDate>Tue, 26 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Phytopharm PLC Stopping R&amp;D Spending, Cutting Headcount  </title><link>http://www.stockmarketwire.com/article/4561778/Phytopharm-reviews-options-after-bleak-Cogane-trials.html</link><description>Drug development company, Phytopharm, has begun talks with potential buyers for the company after it confirmed the results of its Phase II clinical trial of Cogane in Parkinson's disease, which showed that the drug had demonstrated no clinically meaningful efficacy. Those results were first announced in February, sparking a massive sell off in the company's stock which now trades at just over a tenth...</description><pubDate>Tue, 26 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>After Bankruptcy, PRACS Institute (Formerly known as Cetero Research) Lays Off Workers  </title><link>http://www.thedickinsonpress.com/event/article/id/66669/</link><description>PRACS Institute, the contract research organization that emerged from troubled Cary CRO Cetero Research, was closed this week less than a year after emerging from bankruptcy and this time it looks like the company has dosed its last patient. The CRO laid off all its workers and shut down operations at its Fargo, N.D. headquarters, Toronto and St. Louis, according to news reports in each of those three...</description><pubDate>Tue, 26 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Actavis to Add 220 Jobs in Florida  </title><link>http://www.bizjournals.com/southflorida/news/2013/03/21/activis-adding-220-pharmaceutical-jobs.html</link><description>Actavis has announced plans to add 220 jobs and expand its pharmaceutical manufacturing plant in Davie, after qualifying for $2.81 million in state and local incentives. The New Jersey-based company (NYSE: ACT), formerly known as Watson Pharmaceuticals, entered Broward County in 2006 when it acquired generic drug maker Andrx. Now, it has pledged to invest $40.5 million to expand its Davie facility...</description><pubDate>Mon, 25 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>AstraZeneca PLC: 2300 More Layoffs; Global Total Now 5050  </title><link /><description>SDERTLJE, Sweden--(BUSINESS WIRE)--Regulatory News: AstraZeneca (STO:AZN) (LSE:AZN) will today outline its strategy to return to growth and achieve scientific leadership. Results of the annual strategy review will be presented at AstraZenecas Investor Day briefing in New York.&lt;/p&gt;&lt;p&gt;Chief Executive Officer, Pascal Soriot said: AstraZeneca is committed to delivering great medicines to patients...</description><pubDate>Fri, 22 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>MedImmune to Gain 300 New Jobs Under AstraZeneca PLC Shift  </title><link>http://www.washingtonpost.com/blogs/capital-business/post/medimmune-gains-300-jobs-in-astrazeneca-consolidation/2013/03/18/43337710-9001-11e2-9abd-e4c5c9dc5e90_blog.html</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?CustomerId136934"&gt;Hey, MedImmune's hiring!&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;MedImmune's Gaithersburg headquarters will gain 300 jobs under a U.S. consolidation by parent AstraZeneca PLC, the companies announced Monday. The move follows management changes at both companies. Pascal Soriot was named CEO of London-based AstraZeneca in August, and early this year...</description><pubDate>Wed, 20 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Gerresheimer to Bring 120 Jobs to GA  </title><link>http://www.thecitizen.com/articles/03-17-2013/plant-expansion-bring-120-jobs-ptc</link><description>A 180,000 square foot addition to a Peachtree City industry was approved by the Planning Commission Monday night. Beyond that big addition, the project is anticipated to make way for 120 or more new jobs at Gerresheimer, located off Ga. Highway 74 South in the citys industrial park. Gerresheimer is known as the European market leader for manufacturing medical drug-delivery plastic systems. It also...</description><pubDate>Tue, 19 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Affymax, Inc. May File for Bankruptcy; Cuts 75 Pct of Workforce  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290891&amp;full=1</link><description>PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it will reduce its workforce as part of a plan to focus the companys resources on the ongoing investigation of reported hypersensitivity reactions in patients receiving OMONTYS (peginesatide) Injection following the nationwide voluntary recall of product from the market. This action will reduce the companys workforce...</description><pubDate>Tue, 19 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>AstraZeneca PLC to Axe 1600 Jobs in Major R&amp;D Overhaul  </title><link>http://www.stockmarketwire.com/article/4556844/AstraZeneca-to-establish-strategic-RD-centres.html</link><description>AstraZeneca is to cut around 1,600 jobs as it overhauls it research operations and consolidates drug development work in three major centres. The move will see the end of drug research at the company's Alderley Park facility in northern England, for many years a hub of the group's R&amp;D efforts, the drugmaker said on Monday.</description><pubDate>Mon, 18 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Neurosearch A/S Takes Steps to Adjust the Organization and Updates on the Company's Strategy  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290849&amp;full=1</link><description>March 18, 2013 -- The transfer of the Huntexil project to Teva Pharmaceutical Industries Ltd. (Teva) is now so advanced that the company foresees a significant reduction in the activity level in the near future. Therefore, the company takes measures to adjust the organisation to the lower activity level and at the same time updates on the company's strategy.&lt;/p&gt;&lt;p&gt;The Board of Directors and the...</description><pubDate>Mon, 18 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Allozyne, Inc. Conducts Round of Employee "Furloughs"  </title><link>http://www.xconomy.com/seattle/2013/03/15/allozyne-conducts-small-round-of-employee-furloughs/</link><description>Seattle-based Allozyne, one of the promising biotech drug developers to graduate from the venture-backed Accelerator, recently conducted a small round of employee furloughs. Allozyne made the latest round of reductions to its payroll a little more than a year after another round of job cuts that I reported here in January 2012. CEO Meenu Chhabra Karson said by e-mail, We did not lay off anyone recently...</description><pubDate>Fri, 15 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>GlaxoSmithKline to Close Sirtris Pharmaceuticals Cambridge Office, Relocate Some Staff to Philly  </title><link>http://www.bizjournals.com/boston/blog/bioflash/2013/03/gsk-to-close-sirtris-pharmas.html</link><description>Pharmaceutical giant GlaxoSmithKline has now confirmed it is proposing to move staff from its research and development complex in Harlow next year (2014). In a statement released after the Star broke the news that the company is planning to close one of its buildings at Pinnacles, the company issued the following statement: We know that opportunities exist to increase collaboration across R&amp;D by effective...</description><pubDate>Wed, 13 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Loss of 400 Jobs as Baxter International, Inc. Invests $35 Million in Puerto Rico  </title><link>http://www.pmlive.com/pharma_news/baxter_to_cut_400_jobs_in_puerto_rico_466903</link><description>Baxter is to cut 400 jobs at a facility in Puerto Rico as part of plans to realign its manufacturing business in North America. Affected workers are based at Baxter's plant in Aibonito, which manufactures injectable drugs and has a workforce of just under 1,000 employees. Local reports say that 100 positions will be gone by June 2013, with the remaining cuts to be implemented gradually. The layoffs...</description><pubDate>Tue, 12 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Major Pharmaceuticals LLC&lt;/b&gt; Proposes New Jobs for Mequon  </title><link>http://www.jsonline.com/blogs/business/196556961.html</link><description>A start-up company formed by the founder of a Milwaukee-area drug ingredient maker is proposing to build a pharmaceutical research and development facility in Mequon, creating 50 jobs. Major Pharmaceuticals LLC wants to develop a two-story, 79,000-square-foot facility on a 7.7-acre parcel immediately south of Executive Drive and east of Commerce St., according to a filing with the city Plan Commission...</description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Merck Serono: Fresh Pipeline Leads Growth but More Jobs Cuts to Come  </title><link>http://www.reuters.com/article/2013/03/07/merckkgaa-results-idUSL6N0BZ12S20130307</link><description>Merck Serono says fast progress in its restructure programme helped double its net savings guidance for 2012 though headcount dropped by almost 2,000 with more cuts to come. </description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289894&amp;full=1</link><description>DOYLESTOWN, Pa.--(BUSINESS WIRE)--Mar 8, 2013 - The Pennsylvania Biotechnology Center, in Doylestown, Pa., managed and established by the Hepatitis B Foundation in 2006 and co-owned with Delaware Valley College, proudly unveils a 2013 Economic Impact Study by Byler Associates, LLC showing impressive results. The news is good, especially for the Bucks County community and State of Pennsylvania as a...</description><pubDate>Fri, 08 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Spirit Pharmaceuticals&lt;/b&gt; Brings 296 Jobs to South Carolina  </title><link>http://www.wltx.com/news/article/225480/2/Drug-Company-Brings-296-Jobs-to-Clarendon-Co</link><description>A pharmaceutical company is building a new facility in Clarendon County, bringing nearly 300 jobs the region. Spirit Pharmaceuticals announced Wednesday their intentions to build a new packaging and manufacturing facility in Summerton. The $12.2 million investment is expected to create 296 new jobs. "It's an exciting time for our company," said Spirit CEO Ajoy Joshi in a statement. "South Carolina...</description><pubDate>Fri, 08 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Teva Pharmaceutical Industries Limited to Cut Jobs Amid $2 Billion Cost-Cut Plan  </title><link>http://www.jewishpress.com/news/breaking-news/teva-cost-cutting-means-lost-israeli-jobs/2013/03/07/</link><description>Teva Pharmaceutical Industries Ltd. (TEVA) may be preparing to cut jobs in its home market of Israel even as local politicians criticize the company for paying too little in taxes. The worlds largest maker of generic drugs has pledged to cut costs by as much as $2 billion in the next five years as part of a new strategy to increase long-term profitability. Part of those savings will probably need...</description><pubDate>Fri, 08 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Bioniche Life Sciences Inc. Reorganizes One of Its Business Units  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289870&amp;full=1</link><description>BELLEVILLE, ON&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 7, 2013&lt;/span&gt; /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it is reorganizing one of its business units with a view to seeking to unlock the value of the Company's core Human Health technology.&lt;/p&gt;&lt;p align"justify"&gt;The reorganization...</description><pubDate>Fri, 08 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Merck Sharp &amp; Dohme to Cut 280 Jobs in Wicklow, Plans to Cease Operations by 2015  </title><link>http://www.rte.ie/news/business/2013/0307/374559-msd-to-close-rathdrum-plant-280-jobs-to-go/</link><description>Two hundred and eighty jobs are being cut at a pharmaceutical company in Co Wicklow. Staff at MSD's Rathdrum site were called to a meeting to discuss the cuts this morning. It is understood the cuts are part of a worldwide reduction in costs at the company. Their plant in Rathrdum will cease operations by the end of 2015. The company have been in Wicklow since 1961. Rathdrum has been a significant...</description><pubDate>Thu, 07 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Venezuelan Pharmaceutical Firm, Dubbed "" to Relocate to Florida, Bringing New Jobs  </title><link>http://www.sun-sentinel.com/news/broward/tamarac/fl-sf-business-0306-20130307,0,6364972.story</link><description>After considering Atlanta and other parts of Georgia, plus parts of Florida, a Venezuelan pharmaceutical company has decided to make Tamarac its home. The company, which is moving out of Venezuela partly because of the country's political and economic crises, has plans for a capital investment of $50 million and is expected to create 100 high-paying jobs over three years. It will manufacture prescription...</description><pubDate>Thu, 07 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Enterprise Ireland Biotechnology Directorate: High Potential Start Ups to Create 1,600 Jobs  </title><link>http://www.independent.ie/business/irish/more-than-1600-jobs-being-created-by-firms-backed-by-enterprise-ireland-29113735.html</link><description>More than 1,600 new jobs are to be created by 97 new start-up companies supported by Enterprise Ireland in 2012. The companies, which are part of the government agencys high potential start-up unit, are set to generate over 300 million in annual sales and operate in a wide range of sectors including financial services, ICT, games, pharmaceuticals and medical devices.</description><pubDate>Thu, 07 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc.'s Zoetis Bringing 400 Jobs to Florham Park  </title><link>http://www.nj.com/business/index.ssf/2013/03/florham_park_will_be_headquart.html</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?CustomerId394762"&gt;Hey, Pfizer's hiring!&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;Zoetis, Pfizer's animal health subsidiary, will establish its global headquarters in Florham Park and move 400 employees there from the company's current location in Madison by June, the company announced Tuesday. Formerly Pfizer Animal Health, Zoetis recently became a stand-alone company...</description><pubDate>Wed, 06 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Daiichi Sankyo, Inc. Will Lay Off Up to 300 Positions  </title><link>http://www.njbiz.com/article/20130212/NJBIZ01/130219938/Daiichi-Sankyo%27s-US-layoffs-will-include-25-positions-at-Parsippany-headquarters</link><description>Daiichi Sankyo Inc. today announced it will lay off approximately 25 employees at its Parsippany headquarters and 50 field employees across its regional U.S. offices, as well as another 225 open positions across the company, a spokeswoman told NJBIZ. According to the global pharmaceutical company's website, Daiichi Sankyo has 400 employees at its U.S. headquarters in Parsippany and 300 people in global...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Ashland Inc.  to Move 300 Wayne Jobs  </title><link>http://www.northjersey.com/wayne/194966511_Chemical_company_to_move_300_Wayne_jobs.html</link><description>A chemical manufacturing company will close its Wayne operations and move its 300 employees to other parts of the state, passing on plans to leave New Jersey but dealing another blow to the township's economy. Ashland Specialty Ingredients, which makes chemicals for consumer and commercial products, will relocate most of its workers in the fall to a 200,000-square-foot laboratory and office space in...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Durham???s Cenduit, LLC Adding Space, Workers  </title><link>http://www.bizjournals.com/triangle/news/2013/03/04/durhams-cenduit-adding-space-workers.html?ana=otj</link><description>Clinical supplies management services company Cenduit LLC is expanding its Durham headquarters. Cenduit has about 300 employees worldwide, including 45 in Durham. The local head count is expected to grow to 57 by the end of the year. Jogin Desai, CEO, says the expansion is required to support our global investment in capacity. Our aim is to provide the best possible support to sites and sponsors and...</description><pubDate>Mon, 04 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Genentech Expected to Hire 600 New Employees, Bay Area Included  </title><link>http://sanfrancisco.cbslocal.com/2013/02/22/consumerwatch-genentech-expected-to-hire-600-new-employees/#.USeBSNDI3-0.twitter</link><description>&lt;b&gt;&lt;a href"http://www.biospace.com/jobs/search-results/?CustomerId248101"&gt;Hey, Genentech's hiring!&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;br&gt;Genentech expects to fill nearly 600 new positions this year, many at their South San Francisco headquarters. The Bay Area biotech giant consistently lands on Fortune Magazines list of top companies to work for. Positions vary from the expected MDs and PhDs to IT classifications...</description><pubDate>Mon, 04 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Qualicaps Group to Invest $26 Million, Create 123 Jobs in North Carolina  </title><link>http://www.thetimesnews.com/news/top-news/qualicaps-expanding-in-whitsett-1.100691</link><description>Gov. Pat McCrory on Friday announced a pharmaceutical manufacturer will create 123 jobs with an expansion of its Guilford County facility. Qualicaps Inc., which makes gelatin capsules, plans to invest more than $26 million over the next three years at its facility in Whitsett. The company already employs more than 150 workers at the facility, which serves as Qualicaps Groups North American headquarters...</description><pubDate>Mon, 25 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. to Close CovX Research LLC Unit in San Diego, Axes 100 Jobs  </title><link>http://www.utsandiego.com/news/2013/feb/16/pfizer-cuts-more-than-100-san-diego-jobs-report/</link><description>Pharmaceutical giant Pfizer says it has eliminated 100 jobs in San Diego by closing its CovX unit. News of the closure was released Friday, said spokeswoman Lauren Starr. Like other big pharmaceutical companies, Pfizer has been laying off large numbers of employees at its various research locations over the last few years, and closing some locations entirely. San Diego has lost fewer life science jobs...</description><pubDate>Wed, 20 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Deal Keeps in Long Island, Bringing 150 Jobs  </title><link>http://www.rew-online.com/2013/02/20/deal-keeps-pharma-firm-in-long-island/</link><description>A deal hammered out by Nassau County executive and the Industrial Development Agency will keep a pharma firm located in Westbury and bring 150 jobs to the area. Nassau County Executive Edward P. Mangano and the NCIDA announced the approval of an economic development compact that will allow a pharmaceutical company with 569 employees to remain in Westbury. The compact, which requires the company to...</description><pubDate>Wed, 20 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Bruton&lt;/b&gt; Slammed as GlaxoSmithKline Cuts 94 Jobs  </title><link>http://www.rte.ie/news/business/2013/0218/368414-gsk-cork-airport/</link><description>Minister for Jobs  Richard Bruton has been urged to come to Cork to give a detailed response to the decision by GlaxoSmithKline (GSK) to axe 94 jobs at its Cork centre. The pharmaceutical giant is to let 94 jobs  go over a phased basis at the GSK centre at Cork Airport Business Park. GSK is proposing to move all financial services roles from Cork to the UK this year, as part of a plan to simplify...</description><pubDate>Tue, 19 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Up to 95 Jobs Cut at Huntingdon Life Sciences  </title><link>http://www.bbc.co.uk/news/uk-england-21450998</link><description>Almost 100 people have lost their jobs at pharmaceutical laboratories in Cambridgeshire and Suffolk. In December, Huntingdon Life Sciences said staff would be consulted on the cuts at its headquarters in Alconbury and a centre in Eye. A spokesperson said about 95 people lost their jobs. Most left in January and others will finish on the completion of current projects.</description><pubDate>Thu, 14 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Biopharma Employment Survey Upbeat About 2013  </title><link>http://www.biospace.com/news_story.aspx?StoryID=287468&amp;full=1</link><description>While &lt;a href"http://www.biospace.com/company_index.aspx?IndustryId6"&gt;biopharma job growth&lt;/a&gt; has not completely rebounded from the 200709 recession, and many of the worlds economies continue to struggle, several measures over the past two years suggest that employment will pick up the pace in 2013, a new survey concludes.&lt;br&gt;&lt;br&gt;Of the 5,836 participants completing the 2012 BioSpace Annual...</description><pubDate>Tue, 12 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. Layoffs Slightly Larger Than Projected  </title><link>http://www.theday.com/article/20130211/BIZ02/302119958/1017</link><description>Pfizer Inc. has quietly cut hundreds of jobs at its Groton laboratories over the past year, leaving a workforce that is slightly smaller than what the pharmaceutical giant projected as it announced a downsizing of 1,100 positions two years ago. Pfizer had 4,500 employees - mostly scientists - at its Groton and New London campuses two years ago, when the New York-based company announced a major downsizing...</description><pubDate>Tue, 12 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Daiichi Sankyo, Inc. Reps Charge Sex Discrimination  </title><link>http://www.pharmalot.com/2013/02/daiichi-sankyo-reps-charge-sex-discrimination/</link><description>Yet another drugmaker is being charged with alleged sex discrimination by female employees. The latest instance involves six current and former sales representatives for Daiichi Sankyo, who charge they were subject to discriminatory practices involving pay and promotions, as well as inapproriate conduct in the workplace. The lawsuit, which was filed yesterday in federal court in San Francisco, seeks...</description><pubDate>Tue, 12 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Apotex Corp. Seeks Incentives for 108 Jobs, $103 Million Investment in Coral Springs  </title><link>http://www.bizjournals.com/southflorida/news/2013/02/08/apotex-seeks-incentives-for-108-jobs.html?ana=otj&amp;page=all</link><description>Broward County and Coral Springs are looking to offer Apotex Corp. public incentives to create 108 jobs and invest $102.9 million in a generic drug manufacturing facility in the city. The county commission will hear the incentive offer for the Toronto-based company at the Feb. 12 meeting. Apotex entered Broward in 1999 when it acquired transdermal patch manufacturer Aveva in Miramar. Between Weston...</description><pubDate>Mon, 11 Feb 2013 12:00:00 AM GMT</pubDate></item></channel></rss>